An efficacy study of a metacognitive group intervention for people with schizophrenia
- PMID: 30482631
- DOI: 10.1016/j.psychres.2018.10.037
An efficacy study of a metacognitive group intervention for people with schizophrenia
Abstract
Poor cognitive outcomes among people with schizophrenia are associated with poor function in daily life. Cognitive interventions aimed at improving function lead to better cognitive outcomes, but the question of generalization to real-world functioning remains relevant. The ability to generalize or to apply learned skills in the clinic to everyday functioning must include metacognitive components which are the underlying mechanisms of function. To address such generalization, we developed a metacognitive group intervention based on Toglia's (2005) dynamic interactional model, which aims to promote daily activities and participation by focusing on metacognitive components. We assessed 84 participants with schizophrenia (41 in the control group and 43 in the intervention group) before and after completing the intervention and at a 12-week follow-up. Assessments addressed executive function, performance, and participation. The intervention group's performance, participation, and everyday functions significantly increased post-intervention and at follow-up, compared with the control group. Results provide important information about the potential for change in real-world functioning and a basis for the rationale of employing metacognitive interventions in this population.
Keywords: DIM; Dynamic interactional model; EF; Executive functioning; Metacognition; Metacognitive intervention; Schizophrenia.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
-
[Characteristics and impact of metacognitive deficits in schizophrenia].Encephale. 2013 Apr;39(2):123-9. doi: 10.1016/j.encep.2012.01.009. Epub 2012 Dec 6. Encephale. 2013. PMID: 23219408 Review. French.
-
Metacognition - What did James H. Flavell really say and the implications for the conceptualization and design of metacognitive interventions.Schizophr Res. 2018 Nov;201:20-26. doi: 10.1016/j.schres.2018.06.001. Epub 2018 Jun 12. Schizophr Res. 2018. PMID: 29903626 Review.
-
Study protocol of a randomised clinical trial testing whether metacognitive training can improve insight and clinical outcomes in schizophrenia.BMC Psychiatry. 2020 Jan 29;20(1):30. doi: 10.1186/s12888-020-2431-x. BMC Psychiatry. 2020. PMID: 31996174 Free PMC article. Clinical Trial.
-
Metacognitive Reflection and Insight Therapy for Persons With Severe Negative Symptoms of Schizophrenia.Am J Psychother. 2018 Dec 1;71(4):135-144. doi: 10.1176/appi.psychotherapy.20180036. Epub 2018 Nov 7. Am J Psychother. 2018. PMID: 30400763
-
Findings from a randomized controlled trial of Metacognitive Reflection and Insight Therapy for people with schizophrenia: Effects on metacognition and symptoms.Psychol Psychother. 2024 Nov;97 Suppl 1:75-90. doi: 10.1111/papt.12485. Epub 2023 Jul 31. Psychol Psychother. 2024. PMID: 37522576 Clinical Trial.
Cited by
-
When Distance Becomes Closeness: Distance Learning as a Meaningful Learning Opportunity During the COVID-19 Pandemic.Community Ment Health J. 2024 Jan;60(1):14-26. doi: 10.1007/s10597-022-01029-2. Epub 2022 Sep 29. Community Ment Health J. 2024. PMID: 36173515 Free PMC article.
-
Cognitive behavioural therapy (group) for schizophrenia.Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD009608. doi: 10.1002/14651858.CD009608.pub2. Cochrane Database Syst Rev. 2022. PMID: 35866377 Free PMC article.
-
Looking beyond the laboratory: Exploring behavioral and eye-fixation patterns in individuals with severe mental illness during a real-life supermarket task.Sci Prog. 2023 Jan-Mar;106(1):368504231160415. doi: 10.1177/00368504231160415. Sci Prog. 2023. PMID: 36919454 Free PMC article.
-
Group-Based Metacognitive Reflection and Insight Therapy (MERITg) and Its Relationship to Recovery-Oriented Beliefs in Serious Mental Illness.Behav Sci (Basel). 2024 Jun 22;14(7):520. doi: 10.3390/bs14070520. Behav Sci (Basel). 2024. PMID: 39062343 Free PMC article.
-
Do symptoms moderate the association between participation and executive functions outcomes among people with schizophrenia?BMC Psychiatry. 2023 Jan 17;23(1):42. doi: 10.1186/s12888-022-04510-0. BMC Psychiatry. 2023. PMID: 36650458 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical